Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab Effects on Osteoclasts in Rheumatoid Arthritis (BROCA II)
NCT02035800Phase 4Unknown
- Sponsor
- Université de Sherbrooke
- Start
- May 2013
- Primary completion
- Dec 2018
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in rheumatoid arthritis (RA), sponsored by Université de Sherbrooke. Status: unknown.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02035800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02035800.